Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selection to Reduce Cardiac Resynchronization Therapy Non-Responder Rates

Inclusion Criteria: * Patients will be implanted with an FDA approved St. Jude Medical CRT-D device (i.e. PROMOTE® or newer devices with similar functionality) * Patients will have an approved indication per American College of Cardiology/American Heart Association/Heart Rhythm Society guidelines for implantation of a CRT-D * Patients will receive a new implant or an upgrade from an existing pacemaker or Implantable Cardiovertor Defibrillator with no prior Left Ventricular lead placement * Patients must be in sinus rhythm at the time of enrollment visit and baseline measurements Exclusion Criteria: * Persistent or permanent atrial fibrillation * Heart transplantation * Recent myocardial infarction (\< 90 days) * Contra-indication to contrast agent * Are less than 18 years of age * Are pregnant * Are currently participating in a clinical investigation that includes an active treatment arm * Have a life expectancy of less than 6 months